Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Asthma

Free Subscription 05.01.2026 2 Allergy 1 Chest 1 Clin Exp Allergy 2 Int Arch Allergy Immunol 7 J Asthma 1 J Immunol 2 Pediatr Pulmonol 2 Pediatr Rev 1 PLoS One 7 Respir Med 3 Respir Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Allergy

1. MOERMANS C, Sabbe M, Onssels A, Bricmont N, et al
   Dupilumab Effectiveness in Biologic-Naive and Switched Severe Asthma in Real Life.
   Allergy. 2025 Dec 24. doi: 10.1111/all.70205.
   PubMed        
   
   
2. POTO R, Chan R, Pelaia C, Canonica GW, et al
   The Role of Biologics in Reducing Mucous Plug Burden in Asthma.
   Allergy. 2025 Dec 23. doi: 10.1111/all.70197.
   PubMed         Abstract available
   
   

   
   Chest

3. VYAS DA, Mein SA, Narasimmaraj PR, Tale AP, et al
   Asthma Morbidity and Medicaid Instability: Implications of National Work Requirements.
   Chest. 2025 Dec 30:S0012-3692(25)05953-7. doi: 10.1016/j.chest.2025.
   PubMed        
   
   

   
   Clin Exp Allergy

4. PARIS D, Candia C, Molino A, D'Amato M, et al
   Benralizumab Affects Specific Compartments in Severe Asthma Patients With Chronic Rhinosinusitis and Nasal Polyposis.
   Clin Exp Allergy. 2025;55:1251-1254.
   PubMed        
   
   

   
   Int Arch Allergy Immunol

5. KANG L, Kang L, Sun L, An H, et al
   Expression profile of miR-92a-3p in combined allergic rhinitis and asthma syndrome patients and its correlation with small airway dysfunction.
   Int Arch Allergy Immunol. 2025 Dec 31:1-21. doi: 10.1159/000549433.
   PubMed         Abstract available
   
   
6. HOU H, Xu H, Yang F
   Association of Serum FGL2 Levels with Asthma Severity and Airway Remodeling.
   Int Arch Allergy Immunol. 2025 Dec 30:1-18. doi: 10.1159/000550242.
   PubMed         Abstract available
   
   

   
   J Asthma

7. PAUK N, Valena T, Krcmova I, Heribanova L, et al
   Real-world clinical experience with benralizumab for severe eosinophilic asthma in the Czech Republic: Fewer corticosteroids and better symptom control.
   J Asthma. 2025 Dec 27:1-13. doi: 10.1080/02770903.2025.2610346.
   PubMed         Abstract available
   
   
8. YANG X, Guo Y, Bao M, Lu X, et al
   Therapeutic effects and metabolomics profiles of isoflavone extract of Belamcanda chinensis (L.) DC on house dust mite -induced allergic asthma mice.
   J Asthma. 2025 Dec 27:1-12. doi: 10.1080/02770903.2025.2610345.
   PubMed         Abstract available
   
   
9. MATSUMOTO T, Suga H, Kajiwara Y, Matoba T, et al
   Hidden burden: discrepancies between patient-reported and clinically documented severe asthma exacerbations.
   J Asthma. 2025 Dec 27:1-10. doi: 10.1080/02770903.2025.2610347.
   PubMed         Abstract available
   
   
10. ANDOH AA, Truelove A, Helwig S, Nash MC, et al
    Performance of the Asthma Clinical Score and the Pediatric Respiratory Assessment Measure in obese children presenting to the emergency department for asthma exacerbations.
    J Asthma. 2025 Dec 27:1-13. doi: 10.1080/02770903.2025.2610341.
    PubMed         Abstract available
    
    
11. AKCA SUMENGEN A, Gibson-Young LM, Buckner E, Dorsey L, et al
    Associations of Inhaler Technique, Medication Adherence, and Parental Illness Perception on Asthma Control in Childhood: A Cross-Sectional Observational Study.
    J Asthma. 2025 Dec 26:1-21. doi: 10.1080/02770903.2025.2610344.
    PubMed         Abstract available
    
    
12. INTILI G, Fucarino A, Burgio S, Amico MD, et al
    Ex vivo air-liquid interface respiratory mucosa platform to study type 2-driven Asthma.
    J Asthma. 2025 Dec 26:1-15. doi: 10.1080/02770903.2025.2608988.
    PubMed         Abstract available
    
    
13. YU W, Peng Z, Lu B, Yu Y, et al
    Tanshinone IIA attenuates airway inflammation and airway remodeling in bronchial asthma by inhibiting p38/NF-kappaB and AKT/HIF-1alpha.
    J Asthma. 2025 Dec 22:1-13. doi: 10.1080/02770903.2025.2603318.
    PubMed         Abstract available
    
    

    
    J Immunol

14. MATSUDA M, Fujiwara Y, Yonezawa F, Matsuo K, et al
    Cyclin-dependent kinase (CDK) 8 and its paralog CDK19 develop group 2 innate lymphoid cell-related lung fibrosis by activating STAT5.
    J Immunol. 2025;214:3238-3249.
    PubMed         Abstract available
    
    

    
    Pediatr Pulmonol

15. RASHID MM, Hu N, Chan M, Khan JR, et al
    Risk Factors for Asthma Readmission Among Australian Children- A Population-Based Cohort Study.
    Pediatr Pulmonol. 2025;60:e71433.
    PubMed         Abstract available
    
    
16. KANAI R, Nagao M, Sato Y, Atsuta J, et al
    Early-Onset Wheeze Trajectories in Infants: The Phenotyping of Wheezing Infants (P-WIN) Study.
    Pediatr Pulmonol. 2025;60:e71437.
    PubMed         Abstract available
    
    

    
    Pediatr Rev

17. DE WAAL MALEFYT SK, Powers KE, Krugel C, Kaslovsky R, et al
    Asthma Uncovered: A Comprehensive Look at Epidemiology, Pathophysiology, and Diagnosis.
    Pediatr Rev. 2026;47:3-14.
    PubMed        
    
    
18. FILLEY EP, Varghese NP
    Chronic Dyspnea and Acute Syncope in a 16-Year-Old Girl With Asthma.
    Pediatr Rev. 2026;47:44-49.
    PubMed        
    
    

    
    PLoS One

19. KATARIA A, Daniel J, Isaac B, Thangakunam B, et al
    Predictors of depression in asthma patients in an Indian referral hospital.
    PLoS One. 2026;21:e0338126.
    PubMed         Abstract available
    
    

    
    Respir Med

20. CHEN F, Lu M, Ye J, Zhang L, et al
    Association between fractional exhaled nitric oxide (FeNO) and blood eosinophil count among children and adolescents with asthma in the United States: a population-based study.
    Respir Med. 2025 Dec 31:108630. doi: 10.1016/j.rmed.2025.108630.
    PubMed         Abstract available
    
    
21. JANSON C, Malinovschi A, Borres M, Faner R, et al
    Allergic sensitization in asthma and COPD in the NOVELTY study.
    Respir Med. 2026;251:108605.
    PubMed         Abstract available
    
    
22. CLARK VL, de Oliveira JM, Gibson PG, McDonald VM, et al
    Prevalence and overlap of treatable traits in severe asthma and COPD: A cross-disease comparison in a tertiary care setting.
    Respir Med. 2025;252:108604.
    PubMed         Abstract available
    
    
23. DOMAGALA-MANCZYK I, Miszczuk-Ciesla M, Maskey-Warzechowska M, Zielecki M, et al
    Limitation of the effectiveness of inhalation training in patients with asthma and COPD.
    Respir Med. 2026;251:108603.
    PubMed         Abstract available
    
    
24. JESENAK M, Bobcakova A, Golebski K, Krohn IK, et al
    Airway epithelial barrier integrity: an emerging treatable trait in asthma management.
    Respir Med. 2025;252:108579.
    PubMed         Abstract available
    
    
25. MORIKAWA Y, Morimoto K, Kodani T, Miyahara Y, et al
    Safety and efficacy of a helium-oxygen mix for pediatric respiratory failure associated with anatomical and functional stenotic lesions of the airway: a phase II clinical trial.
    Respir Med. 2026;251:108592.
    PubMed         Abstract available
    
    
26. SARAVANAKUMAR T, Mohanakrishnan R
    Effects of neuromuscular breathing exercise with yogic practices on cardiopulmonary variables among women asthmatic patients: A randomized controlled trial.
    Respir Med. 2025;251:108583.
    PubMed         Abstract available
    
    

    
    Respir Res

27. PIPARIA S, Kho AT, Desai B, Wong R, et al
    A principal component analysis-based endophenotype definition for change in lung function and inhaled corticosteroid treatment response in childhood asthma.
    Respir Res. 2025;26:351.
    PubMed         Abstract available
    
    
28. LEE SE, Kim BK, Kang N, Lee Y, et al
    Asthma remission and its predictors in severe asthma: real-world study from the Korean severe asthma registry.
    Respir Res. 2025 Dec 27. doi: 10.1186/s12931-025-03451.
    PubMed         Abstract available
    
    
29. WANG K, Wu R, Fan M, Jia R, et al
    CPA3 drives the development of asthma by promoting the activation of the JAK/STAT6 pathway.
    Respir Res. 2025 Dec 23. doi: 10.1186/s12931-025-03456.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Asthma is free of charge.